| abstract |
The present invention provides an allergic conjunctivitis treatment eye drop which provides improvement of medication adherence by, for example, reducing the number of instillation times and enabling instillation to be performed while a soft contact lens is worn, and which contains, as an active ingredient, epinastine or a salt thereof at a concentration of 0.1% (w/v) and phosphoric acid or a salt thereof, and is characterized by not containing benzalkonium chloride. |